Lifeboat Foundation

Researchers at Stanford University and Biogen faced skeptics head on, challenging the notion that monoclonal antibodies would never serve as therapeutic agents.

Read more about the journey of resilience and innovation:

The road to developing monoclonal antibodies for effectively targeting cancer was paved with tenacity, passion, and strokes of luck.

Continue reading “The Resilience of Monoclonal Antibodies and their Makers” »

The device, based on simple tetromino shapes, could determine the direction and distance of a radiation source, with fewer detector pixels.

The spread of radioactive isotopes from the Fukushima Daiichi Nuclear Power Plant in Japan in 2011 and the ongoing threat of a possible release of radiation from the Zaporizhzhia nuclear complex in the Ukrainian war zone have underscored the need for effective and reliable ways of detecting and monitoring radioactive isotopes. Less dramatically, everyday operations of nuclear reactors, mining and processing of uranium into fuel rods, and the disposal of spent nuclear fuel also require monitoring of radioisotope release.

Innovative Sensor Design Inspired by “Tetris”

A research group from the Ulsan National Institute of Science and Technology (UNIST), led by Professor Jonwoo Jeong of the Department of Physics, has recently discovered a groundbreaking principle of motion at the microscopic scale. Their findings reveal that objects can achieve directed movement simply by periodically changing their sizes within a liquid crystal medium. This innovative discovery holds significant potential for numerous fields of research and could lead to the development of miniature robots in the future.

In their research, the team observed that air bubbles within the liquid crystal could move in one direction by altering their sizes periodically, contrary to the symmetrical growth or contraction typically seen in air bubbles in other mediums. By introducing air bubbles, comparable in size to a human hair, into the liquid crystal and manipulating the pressure, the researchers were able to demonstrate this extraordinary phenomenon.

Empowering universities to remain at the forefront of AI research will be key to realizing the field’s long-term potential.

Engineers and developers at Intel are always working to push the boundaries of what’s possible, leaning on Moore’s Law — the idea that the number of transistors on a single chip will double every two years with a minimal increase in cost.

But over the last five years, Intel has had its ups and downs, demonstrated by the wavering value of its stock. It went from a high of $68 per share to more recently trading at $36 per share.

Continue reading “Machine at Intel’s Hillsboro campus can produce chips so advanced, they don’t yet exist” »

HELIOS is an advanced solar sail concept being evaluated by NASA’s Space Technology Mission Directorate (STMD).

NASA’s STMD rapidly develops, demonstrates, and infuses revolutionary, high-payoff technologies through transparent, collaborative partnerships, expanding the boundaries of the aerospace enterprise.

Continue reading “HELIOS advanced solar sail concept” »

Brighter with Herbert.

An innovative programmable tool for targeting nucleic acids has been created, utilizing a prokaryotic immune defense system—and it is not CRISPR-Cas. Russian Academy of Sciences researchers have successfully re-engineered prokaryotic Argonautes (pAgos) to utilize RNA guides for locating nucleic acid sequences. These systems have been modified to form a complex with effector nucleases.

The researchers employed a two-component system known as SPARDA (short prokaryotic Argonaute, DNase, and RNase-associated) to effectively identify DNA sequences with a notable level of sensitivity and induce collateral nuclease activity. SPARDA and other concise pAgos systems that encode diverse effectors have the potential to offer a novel programmable tool for the field of biotechnology.

The research article “DNA-targeting short Argonautes complex with effector proteins for collateral nuclease activity and bacterial population immunity” was published in Nature Microbiology.

I found this on NewsBreak: Vaccine breakthrough means no more chasing strains.